Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus

被引:46
作者
Bons, N
Lehmann, S
Mestre-Francès, N
Dormont, D
Brown, P
机构
[1] NINCDS, NIH, Bethesda, MD 20892 USA
[2] Atom Energy Commiss, Neurovirol Serv, Fontenay Aux Roses, France
[3] Natl Ctr Sci Res, Inst Human Genet, Montpellier, France
[4] Univ Montpellier 2, Sch Adv Studies, Lab Funct Neuropathol, Montpellier, France
关键词
D O I
10.1046/j.1537-2995.2002.00098.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: More than 100 cases of variant CJD resulting from infections with bovine spongiform encephalopathy (BSE) have accumulated in the United Kingdom since 1995. Concern about the possibility of secondary transmissions via blood and blood components donated by infected individuals has prompted a variety of international donor deferral policies that will continue until laboratory and epidemiologic evidence provides a consensus about potential risk. STUDY DESIGN AND METHODS: BSE was passaged through macaque monkeys and then adapted to the prosimian microcebe (Microcebus murinus). Brain homogenate and buffy coat from an affected microcebe were separately inoculated intracerebrally into three healthy microcebes (two animals received brain and one received buffy coat). RESULTS: All three inoculated microcebes became ill after incubation periods of 16 to 18 months. Clinical, histopathologic, and immunocytologic features were similar in each of the recipients. CONCLUSION: Buffy coat from a symptomatic microcebe infected 17 months earlier with BSE contained the infectious agent. This observation represents the first documented transmission of BSE from the blood of an experimentally infected primate, which in view of rodent buffy coat infectivity precedents and the known host range of BSE is neither unexpected nor cause for alarm.
引用
收藏
页码:513 / 516
页数:4
相关论文
共 10 条
[1]  
Bons N, 1998, BRAIN RES BULL, V46, P1
[2]   Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents [J].
Bons, N ;
Mestre-Frances, N ;
Belli, P ;
Cathala, F ;
Gajdusek, DC ;
Brown, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :4046-4051
[3]  
BONS N, 2002, CR HEBD ACAD SCI, V365, P1
[4]   Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans [J].
Brown, P ;
Cervenáková, L ;
McShane, LM ;
Barber, P ;
Rubenstein, R ;
Drohan, WN .
TRANSFUSION, 1999, 39 (11-12) :1169-1178
[5]   Transfusion medicine and spongiform encephalopathy [J].
Brown, P .
TRANSFUSION, 2001, 41 (04) :433-436
[6]   Detection of variant Creutzfeld-Jakob disease infectivity in extraneural tissues [J].
Bruce, ME ;
McConnell, I ;
Will, RG ;
Ironside, JW .
LANCET, 2001, 358 (9277) :208-209
[7]   Transmission of BSE by blood transfusion in sheep [J].
Houston, F ;
Foster, JD ;
Chong, A ;
Hunter, N ;
Bostock, CJ .
LANCET, 2000, 356 (9234) :999-1000
[8]   BSE transmission to macaques [J].
Lasmezas, CI ;
Deslys, JP ;
Demaimay, R ;
Adjou, KT ;
Lamoury, F ;
Dormont, D ;
Robain, O ;
Ironside, J ;
Hauw, JJ .
NATURE, 1996, 381 (6585) :743-744
[9]   Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease:: Implications for human health [J].
Lasmézas, CI ;
Fournier, JG ;
Nouvel, V ;
Boe, H ;
Marcé, D ;
Lamoury, F ;
Kopp, N ;
Hauw, JJ ;
Ironside, J ;
Bruce, M ;
Dormont, D ;
Deslys, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :4142-4147
[10]   Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies [J].
Wilson, K ;
Code, C ;
Ricketts, MN .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7252) :17-19